These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4144250)

  • 21. Anticholinergic potentiation of amphetamine: reinforcement schedule effects.
    Ray OS; Bivens LW
    Arch Int Pharmacodyn Ther; 1968 Apr; 172(2):414-20. PubMed ID: 5684252
    [No Abstract]   [Full Text] [Related]  

  • 22. [NEW ANTIPARKINSONIAN DRUGS].
    LEREBOULLET J
    Rev Prat; 1964 Dec; 14():SUPPL:178-83. PubMed ID: 14243585
    [No Abstract]   [Full Text] [Related]  

  • 23. Depression by antiparkinson drugs of reserpine rigidity.
    Jurna I
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968 May; 260(1):80-8. PubMed ID: 4236376
    [No Abstract]   [Full Text] [Related]  

  • 24. Controlled studies of antiparkinsonism agents in the treatment of drug-induced extrapyramidal sympttoms.
    Simpson GM
    Acta Psychiatr Scand Suppl; 1970; 212():44-51. PubMed ID: 4917971
    [No Abstract]   [Full Text] [Related]  

  • 25. Central and peripheral actions of anticholinergic drugs when administered with triflupromazine.
    Brimblecombe RW; Green DM; Aldous FA; Thompson PB
    Neuropharmacology; 1971 Jan; 10(1):93-101. PubMed ID: 5569310
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacological study of piroheptine, a new antiparkinson drug. II. Anticholinergic, antihistaminic, and psychopharmacological actions and toxicity.
    Hitomi M; Watanabe N; Kumadaki N; Kumada S
    Arzneimittelforschung; 1972 Jun; 22(6):961-6. PubMed ID: 4403219
    [No Abstract]   [Full Text] [Related]  

  • 27. Sensitivity changes to morphine and other drugs induced by cholinergic blockade.
    Contreras E; Tamayo L; Quijada L
    Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):206-12. PubMed ID: 1171661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pharmacology of azabicyclane, a new analgesic agent.
    Kobayashi S; Hasegawa K; Oshima T; Takagi H
    Toxicol Appl Pharmacol; 1970 Sep; 17(2):344-54. PubMed ID: 5528556
    [No Abstract]   [Full Text] [Related]  

  • 29. [Nicotinolytic action of antiparkinson drugs on rat diaphragm preparations].
    Walther H
    Acta Biol Med Ger; 1967; 18(6):733-9. PubMed ID: 5588995
    [No Abstract]   [Full Text] [Related]  

  • 30. Anticholinergic drugs potentiate dopamine D1 but not D2 antagonists on a conditioned avoidance task in rats.
    Iorio LC; Cohen M; Coffin VL
    J Pharmacol Exp Ther; 1991 Jul; 258(1):118-23. PubMed ID: 1830098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Action of analgesics on 2 shunning behaviors in rats].
    Dallemagne G
    J Physiol (Paris); 1968; 60 Suppl 2():427-8. PubMed ID: 5734958
    [No Abstract]   [Full Text] [Related]  

  • 32. Operant behavior in the morphine-dependent rhesus monkey.
    Holtzman SG; Villarreal JE
    J Pharmacol Exp Ther; 1973 Mar; 184(3):528-41. PubMed ID: 4631467
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of some anticholinergic drugs on water maze learned behaviour in mice.
    Castellano C
    Psychopharmacologia; 1971; 21(4):361-9. PubMed ID: 5098934
    [No Abstract]   [Full Text] [Related]  

  • 34. Biliary-duodenal dynamics in man. Cineradiographic and manometric studies following administration of drugs and hormones.
    Salik JO; Siegel CI; Mendeloff AI
    Radiology; 1973 Jan; 106(1):1-11. PubMed ID: 4630129
    [No Abstract]   [Full Text] [Related]  

  • 35. [Analysis of neurochemical mechanisms of one form of intra-species behavior].
    Burov IuV; Speranskaia NP
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1974; 24(2):301-5. PubMed ID: 4151187
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of cholinergic antagonists on increases of spontaneous locomotor activity and body weight induced by the administration of morphine to tolerant rats.
    Oka T; Nozaki M; Hosoya E
    Psychopharmacologia; 1972; 23(3):231-7. PubMed ID: 5026946
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparative study of anticholinergic psychotomimetic agents in mice and dogs.
    Cohen M
    Arch Int Pharmacodyn Ther; 1967 Oct; 169(2):412-20. PubMed ID: 6064569
    [No Abstract]   [Full Text] [Related]  

  • 38. Anticataleptic effect of taurine: interaction with antiparkinsonian agents.
    Zebrowska-Lupina I; Porowska A
    Pol J Pharmacol Pharm; 1987; 39(4):329-35. PubMed ID: 2897118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of anti-parkinsonian drugs on chlorpromazine-induced depression of operant behaviour.
    Székely JI; Dunai-Kovács Z; Borsy J
    Pharmacology; 1976; 14(3):240-6. PubMed ID: 989172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of the effect of reserpine on motor control by drugs which influence reserpine rigidity.
    Jurna I; Lanzer G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(3):309-24. PubMed ID: 4238719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.